The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and...
MUMBAI: As the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts...
PUNE: Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday described the dispatch of Covishield vaccines for the January 16 national inoculation...